In a study it described as both conclusive and disappointing, WHO said the antiviral drug remdesivir has 'little or no effect on mortality' for patients hospitalized with coronavirus and it doesn't seem to help patients recover any faster, either
In a study it described as both conclusive and disappointing, the World Health Organization said the antiviral drug remdesivir has"little or no effect on mortality" for patients hospitalized with coronavirus and it doesn't seem to help patients recover any faster, either.
Until now, remdesivir has been the only drug that appeared to have specific effects for coronavirus. It was the only drug with an Emergency Use Authorization for Covid-19 from the US Food and Drug Administration.Results of the WHO study have not been published in a peer-reviewed medical journal. But WHO posted them to a pre-print server.
The WHO-led researchers say their trial, called the Solidarity trial, will continue."Newer antiviral drugs, immunomodulators and anti-SARS COV-2 monoclonal antibodies are now being considered for evaluation via the Solidarity Therapeutics trial," WHO said.Monoclonal antibody treatments include Regeneron's dual antibody cocktail and Eli Lilly and Co's double antibody therapy.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Antiviral Drug Remdesivir Proves Ineffective In Treating Covid-19, WHO Study Finds'The main outcomes of mortality, initiation of ventilation and hospitalization duration were not clearly reduced,' the study reads.
Read more »
Remdesivir has 'little or no effect on mortality' of hospitalized Covid-19 patients, WHO study findsThe antiviral drug remdesivir has 'little or no effect on mortality for hospitalized patients' with Covid-19, the WHO says, and it doesn’t seem to help patients recover any faster
Read more »
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patientsGilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
Read more »
Working in child care does not elevate risk of getting Covid-19, Yale study findsWorking in child care does not increase the likelihood of adults contracting Covid-19, according to a new academic study from Yale University published Wednesday.
Read more »
Eli Lilly says other COVID-19 antibody drug trials ongoing after study halted for safety concernEli Lilly & Co on Wednesday said other trials of its experimental coronavirus antibody therapy remain on track after a government-run study testing the treatment in hospitalized COVID-19 patients was paused due to safety concerns.
Read more »